Eye Care Associates
Ophthalmology
Dr. Thomas L. Schwartz, MD
|
|
Give Review
Thomas Schwartz works in the field of Ophthalmology. He attended Baylor College of Medicine. He received 4 awards: "Sarasota Magazine: Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAO)" and "Top MD". Dr. Thomas L. Schwartz has written publications. He has 62 publications published with PubMed. The lastest publication is: 'Molecular etiology of low-penetrance retinoblastoma in two pedigrees.' Thomas Schwartz is registered with Medicare and accepts Medicare payments.
Publications
- A critical appraisal of the selegiline transdermal system for major depressive disorder.
- A neuroscientific update on monoamine oxidase and its inhibitors.
- Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon.
- Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
- Psychopharmacological Practice: The DSM Versus The Brain.
- Fasting plasma triglycerides predict the glycaemic response to treatment of Type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm.
- Obesity and Psychotropics.
- Obesity in adults with serious and persistent mental illness: A review of postulated mechanisms and current interventions.
- Treatment strategies for dosing the second generation antipsychotics.
- Weight gain, obesity, and psychotropic prescribing.
- Acamprosate calcium as augmentation therapy for anxiety Disorders.
- Armodafinil for fibromyalgia fatigue.
- Pregabalin treatment of anxiety in patients with substance use Disorders.
- Psychopharmacology Today: Where are We and Where Do We Go From Here?
- Meralgia paresthetica: anOther complication of antipsychotic-induced weight gain.
- Psychiatric resident and attending diagnostic and prescribing practices.
- Treatment of fibromyalgia.
- Aripiprazole (abilify) and tardive dyskinesia.
- Gamma hydroxy butyric acid and sodium oxybate used to treat posttraumatic stress disorder.
- Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression.
- An eight-week, open-label, prospective case series of acamprosate calcium as monOtherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation ...
- Modafinil treatment for fatigue associated with fibromyalgia.
- An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.
- Tiagabine in anxiety Disorders.
- An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.
- Fibromyalgia-: a review for the psychiatrist.
- A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
- Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
- An open-label study of tiagabine as augmentation therapy for anxiety.
- Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression.
- History repeats itself: pharmacodynamic trends in the treatment of anxiety Disorders.
- Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.
- Psychiatric medication-induced obesity: treatment options.
- Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use: a pilot study.
- Weight decline in patients switching from olanzapine to quetiapine.
- An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
- Psychiatric medication induced obesity: an aetiologic review.
- "A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia".
- Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.
- Psychiatric medication-induced obesity: a review.
- Structural basis for the function of the beta subunit of the eukaryotic signal recognition particle receptor.
- Pharmacokinetics and drug interactions of the sedative hypnotics.
- Prescribing conventional antipsychotics in the era of novel antipsychotics: informed consent issues.
- Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?
- Use of atypical antipsychotics in a Veterans Affairs hospital.
- Modafinil in the treatment of depression with severe comorbid medical illness.
- The role of atypical antipsychotics in the treatment of delirium.
- Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders.
- Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study.
- Ziprasidone treatment of delirium.
- The use of tiagabine augmentation for treatment-resistant anxiety Disorders: a case series.
- Prescribing conventional antipsychotics at two Veterans Administration hospitals: are there geographical differences?
- Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
- Divalproex Sodium Versus Valproic Acid in Hospital Treatment of Psychotic Disorders.
- Treatment of Delirium With Quetiapine.
- Diaphoresis and pruritus with extended-release venlafaxine.
- Assaults by patients on psychiatric residents: a survey and training recommendations.
- Molecular etiology of low-penetrance retinoblastoma in two pedigrees.
- Breast cancer: health education in the workplace.
- Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.
- Antidepressant efficacy and side-effect burden: a quick guide for clinicians.
Schools
University Of Texas Medical Branch At Galveston
VaGood Samaritan Hosps
University Tex Med Br
Baylor College Of Med
Procedures Preformed
- Cataract Removal Surgery
- Cornea Surgery
- Cornea Transplant
- Excision or Destruction of Lesion of Cornea
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anterior Scleritis
- Aphakia and Other Disorders of Lens
- Astigmatism
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Sarasota Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
- Top MD
Education
-
Baylor College of Medicine -
University of Texas Medical Branch Hospitals -
Banner Good Samaritan Medical Center -
University of Texas Medical Branch
Drug Facts
| NPI NUMBER | 1629074414 | |
| NPPES Provider LastName | SCHWARTZ | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 342392340 | |
| NPPES Provider State | FL | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 2054.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629074414 |
| Last Name Of The Provider | SCHWARTZ |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Jeffrey M. Davis, MD |
|
|
Dr. Paul J. Strom Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marion L. Coats, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc A. Grinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen L. Chapman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cornelius H. Halvey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence Hurvitz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William B. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bobby J. Shewmake, MD |
|
|
Dr. Stephen M. Wahl, MD
This Doctor is OpenDoctor Recommended.
|